Treating 4T1 tumour bearing mice with NV-DOXIL-2/IFN-γ led to an 87.9% reduction in tumour volume when compared with free drug and PBS control, indicating a synergistic effect of the combined therapeutic agents [39]. Here, IFNG is linked to neoplasm.